Early Fc-effector antibody signatures impact COVID-19 disease trajectory

Escalera et al., medRxiv, doi:10.64898/2026.02.18.26346542, Feb 2026
Analysis of early immune determinants of COVID-19 disease severity in 37 immunologically naïve hospitalized patients from Spain's first pandemic wave.
Escalera et al., 19 Feb 2026, preprint, 14 authors.
Early Fc-effector antibody signatures impact COVID-19 disease trajectory
Alba Escalera, Ana S Gonzalez-Reiche, Sadaf Aslam, Enrique Bernal, Galit Alter, Amaya Rojo-Fernandez, Alexander Rombauts, Gabriela Abelenda-Alonso, Mary Anne Amper, Venugopalan D Nair, Harm Van Bakel, Jordi Carratalà, Adolfo García-Sastre, Teresa Aydillo
doi:10.64898/2026.02.18.26346542
Why do some individuals develop mild COVID-19 while others progress to severe disease remains a central challenge in SARS-CoV-2 immunology. In this study, we leveraged the BACO Cohorta unique historical cohort of immunologically naïve, hospitalized COVID-19 patients from the first pandemic waveto investigate early immune determinants of clinical disease trajectories. Integrating bulk RNA-seq, Olink proteomics, and systems serology, we identified two fundamentally distinct immune trajectories according to disease phenotypes. Severe patients exhibited upregulation of proinflammatory genes and monocyte-associated transcripts, alongside downregulation of genes related to T cell responses and immune signaling. Notably, an upregulation of inhibitory Fc-receptor-associated gene was also found in severe cases. In contrast, mild cases showed coordinated lymphoid activation and limited inflammation. Building on these findings, we performed a functional profiling of Fc-effector activity in the polyclonal serum of the patients and found that monocyte-mediated phagocytosis was a common feature of mild disease. Interestingly, this response was mainly driven by rapid induction of S1-specific antibodies. Conversely, severe patients tended to generate higher levels of S2-biased antibodies early after infection with poor Fc-effector functionality. Together, these findings demonstrate that .
COMPETING INTERESTS: ACKNOWLEDGEMENTS: We thank the BACO cohort and their families. We also thank Richard DATA AVAILABILITY: All data are available in the manuscript or the supplementary materials.
References
Abdallah, Coindre, Gardet, Meurisse, Naji et al., Leukocyte Immunoglobulin-Like Receptors in Regulating the Immune Response in Infectious Diseases: A Window of Opportunity to Pathogen Persistence and a Sound Target in Therapeutics, Front Immunol, doi:10.3389/fimmu.2021.717998
Ackerman, Moldt, Wyatt, Dugast, Mcandrew et al., A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples, Journal of Immunological Methods, doi:10.1016/j.jim.2010.12.016
Addetia, Crawford, Dingens, Zhu, Roychoudhury et al., Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate, J Clin Microbiol, doi:10.1128/jcm.02107-20
Agrati, Sacchi, Bordoni, Cimini, Notari et al., Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19), Cell Death Differ, doi:10.1038/s41418-020-0572-6
Amanat, Strohmeier, Lee, Bangaru, Ward et al., Murine Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2 Neutralize Authentic Wild-Type SARS-CoV-2 as Well as B.1.1.7 and B.1.351 Viruses and Protect In Vivo in a Mouse Model in a Neutralization-Dependent Manner, mBio, doi:e0100221.10.1128/mBio.01002-21
Anderson, Goodwin, Verma, Arevalo, Bolton et al., Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection, Cell, doi:1810.10.1016/j.cell.2021.02.010
Arunachalam, Wimmers, Mok, Perera, Scott et al., Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans, Science, doi:10.1126/science.abc6261
Aschenbrenner, Mouktaroudi, Krämer, Oestreich, Antonakos et al., Disease severityspecific neutrophil signatures in blood transcriptomes stratify COVID-19 patients, Genome Med, doi:10.1186/s13073-020-00823-5
Aydillo, Escalera, Strohmeier, Aslam, Sanchez-Cespedes et al., Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients, Cell Rep Med, doi:10.1016/j.xcrm.2020.100130
Aydillo, Gonzalez-Reiche, Stadlbauer, Amper, Nair et al., Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination, NPJ Vaccines, doi:10.1038/s41541-022-00583-w
Aydillo, Rombauts, Stadlbauer, Aslam, Abelenda-Alonso et al., Immunological imprinting of the antibody response in COVID-19 patients, Nat Commun, doi:10.1038/s41467-021-23977-1
Barnes, Jette, Abernathy, Dam, Esswein et al., SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies, Nature, doi:10.1038/s41586-020-2852-1
Bauer, Weber, Diehl-Wiesenecker, Galtung, Prpic et al., Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection, Viruses, doi:10.3390/v13122456
Beaudoin-Bussières, Laumaea, Anand, Prévost, Gasser et al., Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals, doi:11.10.1128/mBio.02590-20
Beyer, Mallmann, Xue, Staratschek-Jox, Vorholt et al., High-resolution transcriptome of human macrophages, PLoS One, doi:10.1371/journal.pone.0045466
Blanco-Melo, Nilsson-Payant, Liu, Uhl, Hoagland et al., Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19, Cell, doi:1039.10.1016/j.cell.2020.04.026
Bournazos, Gupta, Ravetch, The role of IgG Fc receptors in antibodydependent enhancement, Nat Rev Immunol, doi:10.1038/s41577-020-00410-0
Bournazos, Vo, Duong, Auerswald, Ly et al., Antibody fucosylation predicts disease severity in secondary dengue infection, Science, doi:10.1126/science.abc7303
Brouwer, Caniels, Van Der Straten, Snitselaar, Aldon et al., Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability, Science, doi:10.1126/science.abc5902
Bruhns, Iannascoli, England, Mancardi, Fernandez et al., Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses, Blood, doi:10.1182/blood-2008-09-179754
Chakraborty, Gonzalez, Edwards, Mallajosyula, Buzzanco et al., Proinflammatory IgG Fc structures in patients with severe COVID-19, Nat Immunol, doi:10.1038/s41590-020-00828-7
Chan, Koh, Ng, Qin, Ooi et al., Early peripheral blood MCEMP1 and HLA-DRA expression predicts COVID-19 prognosis, eBioMedicine, doi:10.1016/j.ebiom.2023.104472
Charytonowicz, Brody, Sebra, Interpretable and context-free deconvolution of multi-scale whole transcriptomic data with UniCell deconvolve, Nat Commun, doi:10.1038/s41467-023-36961-8
Chen, Wu, Guo, Cao, Huang et al., Clinical and immunological features of severe and moderate coronavirus disease 2019, J Clin Invest, doi:10.1172/jci137244
De Jong, Simmons, Thanh, Hien, Smith et al., Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia, Nat Med, doi:10.1038/nm1477
Dechavanne, Nouatin, Adamou, Edslev, Hansen et al., Placental Malaria is Associated with Higher LILRB2 Expression in Monocyte Subsets and Lower Anti-Malarial IgG Antibodies During Infancy, Front Immunol, doi:10.3389/fimmu.2022.909831
Del Sole, Farcomeni, Loffredo, Carnevale, Menichelli et al., Features of severe COVID-19: A systematic review and meta-analysis, Eur J Clin Invest, doi:10.1111/eci.13378
Diao, Wang, Tan, Chen, Liu et al., Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19), Front Immunol, doi:10.3389/fimmu.2020.00827
Dias, Jr, Atyeo, Loos, Montoya et al., Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection, Sci Transl Med, doi:10.1126/scitranslmed.abm3151
Dilillo, Palese, Wilson, Ravetch, Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection, J Clin Invest, doi:10.1172/jci84428
Edgar, Trezise, Anthony, Krammer, Palese et al., Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcγR-dependent protection in vivo, Proc Natl Acad Sci U S A, doi:10.1073/pnas.2314905120
Eisfeld, Halfmann, Wendler, Kyle, Burnum-Johnson et al., Multi-platform 'Omics Analysis of Human Ebola Virus Disease Pathogenesis, Cell Host & Microbe, doi:10.1016/j.chom.2017.10.011
Encinas, Escalera, Aydillo, Iglesias, Nelson et al., SARS-CoV-2 Neutralizing Antibodies in Free-Ranging Fallow Deer (Dama dama) and Red Deer (Cervus elaphus) in Suburban and Rural Areas in Spain, Transbound Emerg Dis, doi:10.1155/2023/3324790
Escalera, Gonzalez-Reiche, Aslam, Mena, Laporte et al., Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission, Cell Host Microbe, doi:377.10.1016/j.chom.2022.01.006
Escalera, Rojo-Fernandez, Rombauts, Abelenda-Alonso, Carratalà et al., SARS-CoV-2 infection induces robust mucosal antibody responses in the upper respiratory tract, iScience, doi:109210.10.1016/j.isci.2024.109210
Fischinger, Fallon, Michell, Broge, Suscovich et al., A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation, Journal of Immunological Methods, doi:10.1016/j.jim.2019.07.002
Freyn, Han, Guthmiller, Bailey, Neu et al., Influenza hemagglutinin-specific IgA Fceffector functionality is restricted to stalk epitopes, Proc Natl Acad Sci U S A, doi:10.1073/pnas.2018102118
Gao, Fan, Zheng, Li, Wang et al., Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain, Human Vaccines & Immunotherapeutics, doi:10.1080/21645515.2022.2055373
Ghaffarpour, Ghazanfari, Ardestani, Naghizadeh, Vaez Mahdavi et al., Cytokine profiles dynamics in COVID-19 patients: a longitudinal analysis of disease severity and outcomes, Sci Rep, doi:10.1038/s41598-025-98505-y
Giamarellos-Bourboulis, Netea, Rovina, Akinosoglou, Antoniadou et al., Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure, Cell Host Microbe, doi:1003.10.1016/j.chom.2020.04.009
Guan, Ni, Hu, Liang, Ou et al., Clinical Characteristics of Coronavirus Disease 2019 in China, N Engl J Med, doi:10.1056/NEJMoa2002032
Guenthoer, Garrett, Lilly, Depierreux, Ruiz et al., The S2 subunit of spike encodes diverse targets for functional antibody responses to SARS-CoV-2, PLoS Pathog, doi:10.1371/journal.ppat.1012383
Hackney, Shivram, Vander Heiden, Overall, Orozco et al., A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling, iScience, doi:.10.1016/j.isci.2023.107813
Hadjadj, Yatim, Barnabei, Corneau, Boussier et al., Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients, Science, doi:10.1126/science.abc6027
Hai, Martínez-Sobrido, Fraser, Ayllon, García-Sastre et al., Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach, J Virol, doi:10.1128/jvi.01213-08
Hao, Hao, Andersen-Nissen, Mauck, Zheng et al., Integrated analysis of multimodal single-cell data, Cell, doi:3529.10.1016/j.cell.2021.04.048
Harriott, Ryan, Proteomic profiling identifies biomarkers of COVID-19 severity, Heliyon, doi:10.1016/j.heliyon.2023.e23320
Hsieh, Goldsmith, Schaub, Divenere, Kuo et al., Structure-based design of prefusion-stabilized SARS-CoV-2 spikes, Science, doi:10.1126/science.abd0826
Huang, Wang, Li, Ren, Zhao et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, doi:10.1016/s0140-6736(20)30183-5
Karsten, Mehta, Shin, Diefenbach, Slein et al., A versatile high-throughput assay to characterize antibody-mediated neutrophil phagocytosis, Journal of Immunological Methods, doi:10.1016/j.jim.2019.05.006
Khoury, Cromer, Reynaldi, Schlub, Wheatley et al., Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection, Nat Med, doi:10.1038/s41591-021-01377-8
Kolberg, Raudvere, Kuzmin, Vilo, Peterson, gprofiler2 --an R package for gene list functional enrichment analysis and namespace conversion toolset g:Profiler, Res, doi:10.12688/f1000research.24956.2
Law, Chen, Shi, Smyth, voom: precision weights unlock linear model analysis tools for RNA-seq read counts, Genome Biology, doi:10.1186/gb-2014-15-2-r29
Lee, Park, Jeong, Ahn, Choi et al., Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19, Sci Immunol, doi:10.1126/sciimmunol.abd1554
Lei, A single transcript for the prognosis of disease severity in COVID-19 patients, Sci Rep, doi:10.1038/s41598-021-91754-7
Li, Dewey, RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome, BMC Bioinformatics, doi:10.1186/1471-2105-12-323
Li, Guo, Tian, Wang, Yang et al., Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis, Med, doi:10.1016/j.medj.2020.07.002
Liao, Liu, Yuan, Wen, Xu et al., Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19, Nat Med, doi:10.1038/s41591-020-0901-9
Liao, Smyth, Shi, featureCounts: an efficient general purpose program for assigning sequence reads to genomic features, Bioinformatics, doi:10.1093/bioinformatics/btt656
Lichterfeld, Yu, The emerging role of leukocyte immunoglobulin-like receptors (LILRs) in HIV-1 infection, J Leukoc Biol, doi:10.1189/jlb.0811442
Liu, Wang, Nair, Yu, Rapp et al., Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike, Nature, doi:10.1038/s41586-020-2571-7
Liu, Zhou, Yang, The cytokine storm of severe influenza and development of immunomodulatory therapy, Cell Mol Immunol, doi:10.1038/cmi.2015.74
Lowery, Sariol, Perlman, Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19, Cell Host & Microbe, doi:10.1016/j.chom.2021.05.004
Lucas, Wong, Klein, Castro, Silva et al., Longitudinal analyses reveal immunological misfiring in severe COVID-19, Nature, doi:10.1038/s41586-020-2588-y
Lévy, Wiedemann, Hejblum, Durand, Lefebvre et al., CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death, iScience, doi:.10.1016/j.isci.2021.102711
Marsh, Hatami, Palese, Specific residues of the influenza A virus hemagglutinin viral RNA are important for efficient packaging into budding virions, J Virol, doi:10.1128/jvi.01144-07
Messner, Demichev, Wendisch, Michalick, White et al., Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection, Cell Syst, doi:14.10.1016/j.cels.2020.05.012
Ming, Li, Wu, Zhang, Zhong et al., Immunoglobulin-Like Transcript 5 Inhibits Macrophage-Mediated Bacterial Killing and Antigen Presentation During Sepsis, J Infect Dis, doi:10.1093/infdis/jiz319
Moraes, Ayo, Elpidio, Souza, Yamanaka et al., HLA-G, LILRB1 and LILRB2 Variants in Zika Virus Transmission from Mother to Child in a Population from South and Southeast of Brazil, Curr Issues Mol Biol, doi:10.3390/cimb44070191
Motsoeneng, Dhar, Nunes, Krammer, Madhi et al., Hemagglutinin Stalk-Specific Fc-Mediated Functions Are Associated With Protection Against Influenza Illness After Seasonal Influenza Vaccination, J Infect Dis, doi:10.1093/infdis/jiae241
Muthuraman, Jackman, Liang, Garrett, Cui et al., Human antibody targeting of coronavirus spike S2 subunit is associated with protection mediated by Fc effector functions, J Virol, doi:10.1128/jvi.01523-25
Nimmerjahn, Ravetch, Fc-receptors as regulators of immunity, Adv Immunol, doi:10.1016/s0065-2776(07)96005-8
Ong, Chan, Leong, Lee, Kalimuddin et al., A Dynamic Immune Response Shapes COVID-19 Progression, Cell Host Microbe, doi:872.10.1016/j.chom.2020.03.021
Prebensen, Lefol, Myhre, Lüders, Jonassen et al., Longitudinal whole blood transcriptomic analysis characterizes neutrophil activation and interferon signaling in moderate and severe COVID-19, Scientific Reports, doi:10.1038/s41598-023-37606-y
Redondo-García, Barritt, Papagregoriou, Yeboah, Frendeus et al., Human leukocyte immunoglobulin-like receptors in health and disease, Front Immunol, doi:10.3389/fimmu.2023.1282874
Ritchie, Phipson, Wu, Hu, Law et al., limma powers differential expression analyses for RNA-sequencing and microarray studies, Nucleic Acids Research, doi:10.1093/nar/gkv007
Rojo-Fernandez, Aslam, Alam, Escalera, Villamandos et al., Systemic and mucosal immune signatures of protection against SARS-CoV-2 transmission in humans, Cell Rep Med, doi:10.1016/j.xcrm.2025.102505
Sadanandam, Bopp, Dixit, Knapp, Emperumal et al., A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patients, Cell Death Discovery, doi:10.1038/s41420-020-00376-x
Schulte-Schrepping, Reusch, Paclik, Baßler, Schlickeiser et al., Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment, Cell, doi:1423.10.1016/j.cell.2020.08.001
Schäfer, Muecksch, Lorenzi, Leist, Cipolla et al., Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo, J Exp Med, doi:10.1084/jem.20201993
Shiakolas, Kramer, Wrapp, Richardson, Schäfer et al., Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions, Cell Rep Med, doi:10.1016/j.xcrm.2021.100313
Silvin, Chapuis, Dunsmore, Goubet, Dubuisson et al., Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19, Cell, doi:1418.10.1016/j.cell.2020.08.002
Song, Zhang, Fan, Meng, Xu et al., Immunological and inflammatory profiles in mild and severe cases of COVID-19, Nat Commun, doi:10.1038/s41467-020-17240-2
Sterlin, Mathian, Miyara, Mohr, Anna et al., IgA dominates the early neutralizing antibody response to SARS-CoV-2, Science Translational Medicine, doi:10.1126/scitranslmed.abd2223
Sun, He, Liu, Zhu, Zhang et al., Anti-S2 antibodies responsible for the SARS-CoV-2 infection-induced serological crossreactivity against MERS-CoV and MERS-related coronaviruses, Front Immunol, doi:10.3389/fimmu.2025.1541269
Tang, Zeng, Cox, Li, Son et al., Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination, Sci Immunol, doi:4853.10.1126/sciimmunol.add4853
Tortorici, Czudnochowski, Starr, Marzi, Walls et al., Broad sarbecovirus neutralization by a human monoclonal antibody, Nature, doi:10.1038/s41586-021-03817-4
Valle, Kim-Schulze, Huang, Beckmann, Nirenberg et al., An inflammatory cytokine signature predicts COVID-19 severity and survival, Nat Med, doi:10.1038/s41591-020-1051-9
Van Der Touw, Chen, Pan, Chen, LILRB receptor-mediated regulation of myeloid cell maturation and function, Cancer Immunol Immunother, doi:10.1007/s00262-017-2023-x
Walsh, Teijaro, Wilker, Jatzek, Fremgen et al., Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus, Proc Natl Acad Sci U S A, doi:10.1073/pnas.1107024108
Wilk, Rustagi, Zhao, Roque, Martínez-Colón et al., A single-cell atlas of the peripheral immune response in patients with severe COVID-19, Nat Med, doi:10.1038/s41591-020-0944-y
Wu, Chen, Cai, Xia, Zhou et al., Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China, JAMA Intern Med, doi:10.1001/jamainternmed.2020.0994
Yang, Yu, Xu, Shu, Xia et al., Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med, doi:10.1016/s2213-2600(20)30079-5
Yeboah, Papagregoriou, Jones, Chan, Hu et al., LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation, JCI Insight, doi:.10.1172/jci.insight.141593
Zhang, Stacey, D'agostino, Tugg, Marzok et al., Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection, Nat Rev Immunol, doi:10.1038/s41577-022-00813-1
Zhao, Van Woudenbergh, Zhu, Heck, Van Kessel et al., The Orphan Immune Receptor LILRB3 Modulates Fc Receptor-Mediated Functions of Neutrophils, J Immunol, doi:10.4049/jimmunol.1900852
Zhou, Yu, Du, Fan, Liu et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, The Lancet, doi:10.1016/S0140-6736(20)30566-3
Zobel, Wenzel, Krüger, Baumgarten, Wagelöhner et al., Serum interleukin-6, procalcitonin, and Creactive protein at hospital admission can identify patients at low risk for severe COVID-19 progression, Front Microbiol, doi:10.3389/fmicb.2023.1256210
Zohar, Loos, Fischinger, Atyeo, Wang et al., Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality, Cell, doi:1512.10.1016/j.cell.2020.10.052
Zost, Gilchuk, Case, Binshtein, Chen et al., Potently neutralizing and protective human antibodies against SARS-CoV-2, Nature, doi:10.1038/s41586-020-2548-6
DOI record: { "DOI": "10.64898/2026.02.18.26346542", "URL": "http://dx.doi.org/10.64898/2026.02.18.26346542", "abstract": "<jats:title>ABSTRACT</jats:title>\n <jats:p>Why do some individuals develop mild COVID-19 while others progress to severe disease remains a central challenge in SARS-CoV-2 immunology. In this study, we leveraged the BACO Cohort – a unique historical cohort of immunologically naïve, hospitalized COVID-19 patients from the first pandemic wave – to investigate early immune determinants of clinical disease trajectories. Integrating bulk RNA-seq, Olink proteomics, and systems serology, we identified two fundamentally distinct immune trajectories according to disease phenotypes. Severe patients exhibited upregulation of proinflammatory genes and monocyte-associated transcripts, alongside downregulation of genes related to T cell responses and immune signaling. Notably, an upregulation of inhibitory Fc-receptor–associated gene was also found in severe cases. In contrast, mild cases showed coordinated lymphoid activation and limited inflammation. Building on these findings, we performed a functional profiling of Fc-effector activity in the polyclonal serum of the patients and found that monocyte-mediated phagocytosis was a common feature of mild disease. Interestingly, this response was mainly driven by rapid induction of S1-specific antibodies. Conversely, severe patients tended to generate higher levels of S2-biased antibodies early after infection with poor Fc-effector functionality. Together, these findings demonstrate that early S1-directed, Fc-competent humoral immunity is a key determinant of favorable COVID-19 outcomes, while delayed functional maturation and early S2 bias characterized severe disease in the BACO cohort.</jats:p>", "accepted": { "date-parts": [ [ 2026, 2, 19 ] ] }, "author": [ { "ORCID": "https://orcid.org/0000-0003-0061-0768", "affiliation": [ { "name": "Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA" }, { "name": "Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA" } ], "authenticated-orcid": false, "family": "Escalera", "given": "Alba", "sequence": "first" }, { "ORCID": "https://orcid.org/0000-0003-3583-4497", "affiliation": [ { "name": "Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA" } ], "authenticated-orcid": false, "family": "Gonzalez-Reiche", "given": "Ana S.", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA" }, { "name": "Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA" }, { "name": "Department of Health Sciences, University of Burgos, 09001 Burgos, Spain" } ], "family": "Aslam", "given": "Sadaf", "sequence": "additional" }, { "affiliation": [ { "name": "Instituto Murciano de Investigación Biosanitaria, Universidad de Murcia, Hospital General Universitario Reina Sofía, 30003 Murcia, Spain" } ], "family": "Bernal", "given": "Enrique", "sequence": "additional" }, { "affiliation": [ { "name": "The Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA" } ], "family": "Alter", "given": "Galit", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA" }, { "name": "Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA" }, { "name": "Department of Health Sciences, University of Burgos, 09001 Burgos, Spain" } ], "family": "Rojo-Fernandez", "given": "Amaya", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Infectious Diseases, Bellvitge University Hospital, 08907 L’Hospitalet de Llobregat, Spain" }, { "name": "Bellvitge Biomedical Research Institute (IDIBELL), 08907 ĹHospitalet de Llobregat, Spain" } ], "family": "Rombauts", "given": "Alexander", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Infectious Diseases, Bellvitge University Hospital, 08907 L’Hospitalet de Llobregat, Spain" }, { "name": "Bellvitge Biomedical Research Institute (IDIBELL), 08907 ĹHospitalet de Llobregat, Spain" }, { "name": "Center for Biomedical Network Research on Infectious Diseases (CIBERINFEC), Carlos III Health Institute, 28029 Madrid, Spain" } ], "family": "Abelenda-Alonso", "given": "Gabriela", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA" } ], "family": "Amper", "given": "Mary Anne", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA" } ], "family": "Nair", "given": "Venugopalan D.", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-1376-6916", "affiliation": [ { "name": "Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA" }, { "name": "Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA" }, { "name": "Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA" } ], "authenticated-orcid": false, "family": "van Bakel", "given": "Harm", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Infectious Diseases, Bellvitge University Hospital, 08907 L’Hospitalet de Llobregat, Spain" }, { "name": "Bellvitge Biomedical Research Institute (IDIBELL), 08907 ĹHospitalet de Llobregat, Spain" }, { "name": "Center for Biomedical Network Research on Infectious Diseases (CIBERINFEC), Carlos III Health Institute, 28029 Madrid, Spain" }, { "name": "Department of Clinical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, 08907 ĹHospitalet de Llobregat, Spain" } ], "family": "Carratalà", "given": "Jordi", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA" }, { "name": "Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA" }, { "name": "Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA" }, { "name": "Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA" }, { "name": "The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA" } ], "family": "García-Sastre", "given": "Adolfo", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0003-3086-1058", "affiliation": [ { "name": "Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA" }, { "name": "Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA" } ], "authenticated-orcid": false, "family": "Aydillo", "given": "Teresa", "sequence": "additional" } ], "container-title": [], "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2026, 2, 20 ] ], "date-time": "2026-02-20T03:15:13Z", "timestamp": 1771557313000 }, "deposited": { "date-parts": [ [ 2026, 2, 21 ] ], "date-time": "2026-02-21T16:25:19Z", "timestamp": 1771691119000 }, "group-title": "Infectious Diseases (except HIV/AIDS)", "indexed": { "date-parts": [ [ 2026, 2, 21 ] ], "date-time": "2026-02-21T17:07:19Z", "timestamp": 1771693639912, "version": "3.50.1" }, "institution": [ { "name": "medRxiv" } ], "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2026, 2, 19 ] ] }, "license": [ { "URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2026, 2, 19 ] ], "date-time": "2026-02-19T00:00:00Z", "timestamp": 1771459200000 } } ], "link": [ { "URL": "https://syndication.highwire.org/content/doi/10.64898/2026.02.18.26346542", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "54368", "original-title": [], "posted": { "date-parts": [ [ 2026, 2, 19 ] ] }, "prefix": "10.64898", "published": { "date-parts": [ [ 2026, 2, 19 ] ] }, "publisher": "openRxiv", "reference": [ { "DOI": "10.1056/NEJMoa2002032", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.1" }, { "DOI": "10.1016/s0140-6736(20)30183-5", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.2" }, { "DOI": "10.1016/j.cell.2020.04.026", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.3" }, { "DOI": "10.1038/s41591-020-0944-y", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.4" }, { "DOI": "10.1038/s41586-020-2588-y", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.5" }, { "DOI": "10.1016/j.chom.2020.03.021", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.6" }, { "DOI": "10.1126/science.abc6027", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.7" }, { "DOI": "10.1016/j.chom.2021.05.004", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.8" }, { "DOI": "10.1016/S0140-6736(20)30566-3", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.9" }, { "DOI": "10.1172/jci137244", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.10" }, { "DOI": "10.1126/sciimmunol.abd1554", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.11" }, { "DOI": "10.1038/cmi.2015.74", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.12" }, { "DOI": "10.1073/pnas.1107024108", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.13" }, { "DOI": "10.1038/nm1477", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.14" }, { "DOI": "10.1038/s41598-025-98505-y", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.15" }, { "DOI": "10.3389/fmicb.2023.1256210", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.16" }, { "DOI": "10.1126/science.abc6261", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.17" }, { "DOI": "10.1038/s41420-020-00376-x", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.18" }, { "DOI": "10.3390/v13122456", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.19" }, { "DOI": "10.3389/fimmu.2020.00827", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.20" }, { "DOI": "10.1038/s41591-020-0901-9", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.21" }, { "DOI": "10.1111/eci.13378", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.22" }, { "DOI": "10.1001/jamainternmed.2020.0994", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.23" }, { "DOI": "10.1016/s2213-2600(20)30079-5", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.24" }, { "DOI": "10.1038/s41586-020-2571-7", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.25" }, { "DOI": "10.1038/s41586-020-2852-1", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.26" }, { "DOI": "10.1038/s41586-020-2548-6", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.27" }, { "DOI": "10.1016/j.cell.2021.02.010", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.28" }, { "DOI": "10.3389/fimmu.2025.1541269", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.29" }, { "DOI": "10.1080/21645515.2022.2055373", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.30" }, { "DOI": "10.1038/s41577-022-00813-1", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.31" }, { "DOI": "10.1038/s41577-020-00410-0", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.32" }, { "DOI": "10.1182/blood-2008-09-179754", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.33" }, { "DOI": "10.1016/j.xcrm.2020.100130", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.34" }, { "DOI": "10.1172/JCI84428", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.35" }, { "DOI": "10.1073/pnas.2314905120", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.36" }, { "DOI": "10.1073/pnas.2018102118", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.37" }, { "DOI": "10.1093/infdis/jiae241", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.38" }, { "DOI": "10.1038/s41467-021-23977-1", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.39" }, { "DOI": "10.1016/j.isci.2024.109210", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.40" }, { "DOI": "10.1038/s41591-020-1051-9", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.41" }, { "DOI": "10.1016/j.cels.2020.05.012", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.42" }, { "DOI": "10.1016/j.heliyon.2023.e23320", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.43" }, { "DOI": "10.1016/j.isci.2023.107813", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.44" }, { "DOI": "10.1038/s41598-021-91754-7", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.45" }, { "DOI": "10.1007/s00262-017-2023-x", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.46" }, { "DOI": "10.3389/fimmu.2023.1282874", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.47" }, { "DOI": "10.1172/jci.insight.141593", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.48" }, { "DOI": "10.4049/jimmunol.1900852", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.49" }, { "DOI": "10.1016/S0065-2776(07)96005-8", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.50" }, { "DOI": "10.1038/s41541-022-00583-w", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.51" }, { "DOI": "10.1038/s41467-023-36961-8", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.52" }, { "DOI": "10.1126/science.abc5902", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.53" }, { "DOI": "10.1371/journal.ppat.1012383", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.54" }, { "DOI": "10.1038/s41586-021-03817-4", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.55" }, { "DOI": "10.1128/JVI.01213-08", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.56" }, { "DOI": "10.1128/JVI.01144-07", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.57" }, { "DOI": "10.1128/jcm.02107-20", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.58" }, { "DOI": "10.1038/s41591-021-01377-8", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.59" }, { "DOI": "10.1084/jem.20201993", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.60" }, { "DOI": "10.1128/mBio.02590-20", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.61" }, { "DOI": "10.1016/j.cell.2020.10.052", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.62" }, { "DOI": "10.1038/s41467-020-17240-2", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.63" }, { "DOI": "10.1038/s41418-020-0572-6", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.64" }, { "DOI": "10.1126/sciimmunol.add4853", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.65" }, { "DOI": "10.1126/scitranslmed.abd2223", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.66" }, { "DOI": "10.1038/s41590-020-00828-7", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.67" }, { "DOI": "10.1016/j.xcrm.2025.102505", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.68" }, { "DOI": "10.1016/j.cell.2020.08.001", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.69" }, { "DOI": "10.1016/j.cell.2020.08.002", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.70" }, { "DOI": "10.1016/j.chom.2020.04.009", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.71" }, { "DOI": "10.1038/s41598-023-37606-y", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.72" }, { "DOI": "10.1186/s13073-020-00823-5", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.73" }, { "DOI": "10.1016/j.ebiom.2023.104472", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.74" }, { "DOI": "10.1016/j.medj.2020.07.002", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.75" }, { "DOI": "10.1016/j.isci.2021.102711", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.76" }, { "DOI": "10.1371/journal.pone.0045466", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.77" }, { "DOI": "10.3389/fimmu.2021.717998", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.78" }, { "DOI": "10.1093/infdis/jiz319", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.79" }, { "DOI": "10.3389/fimmu.2022.909831", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.80" }, { "DOI": "10.1189/jlb.0811442", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.81" }, { "DOI": "10.3390/cimb44070191", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.82" }, { "DOI": "10.1126/science.abc7303", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.83" }, { "DOI": "10.1126/scitranslmed.abm3151", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.84" }, { "DOI": "10.1128/jvi.01523-25", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.85" }, { "DOI": "10.1016/j.xcrm.2021.100313", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.86" }, { "DOI": "10.1016/j.cell.2021.04.048", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.87" }, { "DOI": "10.1128/mBio.01002-21", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.88" }, { "DOI": "10.1155/2023/3324790", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.89" }, { "DOI": "10.1126/science.abd0826", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.90" }, { "DOI": "10.1016/j.chom.2022.01.006", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.91" }, { "DOI": "10.1016/j.chom.2017.10.011", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.92" }, { "DOI": "10.1093/bioinformatics/btt656", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.93" }, { "DOI": "10.1186/1471-2105-12-323", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.94" }, { "DOI": "10.1186/gb-2014-15-2-r29", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.95" }, { "DOI": "10.1093/nar/gkv007", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.96" }, { "DOI": "10.12688/f1000research.24956.2", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.97" }, { "DOI": "10.1016/j.jim.2010.12.016", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.98" }, { "DOI": "10.1016/j.jim.2019.05.006", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.99" }, { "DOI": "10.1016/j.jim.2019.07.002", "doi-asserted-by": "publisher", "key": "2026022108250924000_2026.02.18.26346542v1.100" } ], "reference-count": 100, "references-count": 100, "relation": {}, "resource": { "primary": { "URL": "http://medrxiv.org/lookup/doi/10.64898/2026.02.18.26346542" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "subtype": "preprint", "title": "Early Fc-effector antibody signatures impact COVID-19 disease trajectory", "type": "posted-content" }